Auria® Biological Breast Cancer Screening Test
West Nile Virus (WNV) Antibody, IgM
Kidney transplantation
Alpha 1 Microglobulin, 24 Hour, Urine
Empyema
Insulin Antibody
Alpha-L-Iduronidase (IDUA) Gene Mutation Analysis, Full Sequencing
Creatine Kinase MB (CKMB)
Hemoglobin Electrophoresis
Hepatitis A Virus (HAV) Antibody, IgM
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
References
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now
Loading...